Antisoma to present at Rodman and Renshaw Healthcare Conference on November 8
2 November 2006, London, UK – Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its Chief Executive Officer, Glyn Edwards, will be presenting at the Rodman & Renshaw 8 th Annual Global Healthcare Conference in New York on Wednesday 8 November.
Mr Edwards’s presentation will take place at 3.50pm EST. A live webcast of the presentation will be available to all parties on Antisoma’s website www.antisoma.com
It is recommended that viewers log on 15 minutes early in order to register and download any necessary software.
Background on Antisoma
Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information.
- Contact Information
- Katherine Harrison
- Communications Manager
- Antisoma plc
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.